Amgen Inc. buy BMO Capital Markets
Start price
03.05.24
/
50%
€292.50
Target price
03.05.25
€329.44
Performance (%)
-15.61%
End price
04.05.25
€246.85
Summary
This prediction ended on 04.05.25 with a price of €246.85. The prediction for Amgen Inc. disappointed with a performance of -15.61%. BMO_Capital_Markets has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.50 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 0.215% | 0.215% | 9.172% |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten